论文部分内容阅读
自1982年以来,我们用免疫酶法对110例治疗前鼻咽癌患者以及非鼻咽癌对照组82人(其中包括正常人群62名、头颈部其它肿瘤病人20名)进行了EB病毒壳抗原的免疫球蛋白A(VCA-IgA)抗体测定。对治疗前鼻咽癌病人的性别、年龄、颈淋巴转移灶、临床分期与VCA-IgA抗体滴度水平的关系进行了统计学分析,现将结果报告如下。
Since 1982, we have performed EB virus shell immunoenzymes on 110 patients with pre-nasopharyngeal cancer and 82 non-nasopharyngeal cancer control patients (including 62 normal people and 20 other head and neck cancer patients). Antigen immunoglobulin A (VCA-IgA) antibody assay. The relationship between sex, age, cervical lymph node metastasis, clinical stage and VCA-IgA antibody titer levels in patients with pre-treatment nasopharyngeal carcinoma was statistically analyzed. The results are reported below.